Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $337.08, but opened at $325.85. Bio-Rad Laboratories shares last traded at $325.85, with a volume of 198 shares.
Bio-Rad Laboratories Price Performance
The company has a 50 day moving average price of $336.57 and a 200-day moving average price of $317.92. The company has a quick ratio of 4.52, a current ratio of 6.14 and a debt-to-equity ratio of 0.16. The company has a market cap of $9.12 billion, a price-to-earnings ratio of -11.92 and a beta of 0.72.
About Bio-Rad Laboratories
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
Recommended Stories
- Five stocks we like better than Bio-Rad Laboratories
- Retail Stocks Investing, Explained
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- What Are Dividend Achievers? An Introduction
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- Best Aerospace Stocks Investing
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
